HNOI — HNO International Income Statement
0.000.00%
IndustrialsHighly SpeculativeSmall Cap
- $69.35m
- $70.72m
- $0.01m
Annual income statement for HNO International, fiscal year end - October 31st, USD millions except per share, conversion factor applied.
2009 October 31st | 2010 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | PROSPECTUS | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0.217 | 0 | 0.034 | 0.013 |
Cost of Revenue | |||||
Gross Profit | 0 | -0.115 | 0 | 0.007 | 0.007 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1.07 | 34.4 | 0.133 | 1.09 | 1.43 |
Operating Profit | -1.07 | -34.2 | -0.133 | -1.06 | -1.42 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1.07 | -34.9 | -0.133 | -1.07 | -1.44 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.07 | -34.9 | -0.133 | -1.07 | -1.44 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.07 | -34.9 | -0.133 | -1.07 | -1.44 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -1.07 | -34.9 | -0.133 | -1.07 | -1.44 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -51.2 | -344 | -0.001 | -0.011 | -0.004 |
Dividends per Share |